Candidaemia in Immune-Compromised Hosts: Incidence and Drugs Susceptibility
Received Date: Sep 21, 2012 / Accepted Date: Oct 17, 2012 / Published Date: Oct 20, 2012
We analyzed the different Candidae species isolated from bloodstream infections and the related antifungal
susceptibility pattern over a five-year period (2007-2011) at Policlinico Umberto I of Rome (Italy).
The overall incidence of candidaemia during this range of time accounted for 6.4% with a marked increase from
2007 to 2011 (from 3.83% to 9%). The species isolated were the following: C. albicans (42%) and non-albicans (58%).
In the period 2007-2009, C.krusei was the most frequent species detected among non-albicans species (29.4%),
followed by C.glabrata (20%), whereas during 2010-2011 we found a shift versus C. parapsilosis increasing from 4.6%
C.albicans showed a good susceptibility to the most antifungal agents. C. krusei exhibited a raising resistance to
flucytosin and fluconazole. As for fluconazole, it shows an intrinsic resistance. In C. glabrata we observed increased
resistance especially to fluconazole for which this species shows a Susceptibility Dose-Dependent (SDD). C.tropicalis
had only a resistance to fluconazole (MIC 90%=16 mcg/ml) In vitro activity of the echinocandins resulted to be very
strong for all Candidae species. These drugs have a fungicidal activity and their use is recommended in the most
Our study confirms the high incidence of candidaemia in the setting of critically ill patients. A strong association of
Candidae infection with the presence of Central Venous Catheter (CVC) has been markedly noticed especially in the
years 2009 and 2011 due to a greater use of CVC in our patients. The overall rate of resistance increased over the
study period in all Candidae strains.
Keywords: C. albicans and non-albicans; Candidaemie; Antimycotic agents susceptibility; Azoles; Echinocandins; Central Venous Catheter (CVC)
Citation: Mascellino MT, Raponi G, Oliva A, Mastroianni CM, Vullo V (2012) Candidaemia in Immune-Compromised Hosts: Incidence and Drugs Susceptibility. J Clin Exp Pathol 2:131. Doi: 10.4172/2161-0681.1000131
Copyright: © 2012 Mascellino MT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 12975
- [From(publication date): 11-2012 - Jul 27, 2021]
- Breakdown by view type
- HTML page views: 9086
- PDF downloads: 3889